Tenaya Therapeutics Inc (TNYA)
4.65
+0.40
(+9.41%)
USD |
NASDAQ |
May 17, 16:00
4.65
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Cash from Investing (Quarterly): -4.489M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -4.489M |
| December 31, 2023 | -14.92M |
| September 30, 2023 | 30.49M |
| June 30, 2023 | 25.08M |
| March 31, 2023 | 8.061M |
| December 31, 2022 | 5.974M |
| September 30, 2022 | 31.03M |
| June 30, 2022 | 30.21M |
| March 31, 2022 | 16.43M |
| Date | Value |
|---|---|
| December 31, 2021 | -62.58M |
| September 30, 2021 | -168.42M |
| June 30, 2021 | -3.236M |
| March 31, 2021 | -4.323M |
| December 31, 2020 | -8.177M |
| September 30, 2020 | -0.162M |
| June 30, 2020 | -0.989M |
| March 31, 2020 | 2.318M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-168.42M
Minimum
Sep 2021
31.03M
Maximum
Sep 2022
-6.923M
Average
-0.162M
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | -14.24M |
| Corvus Pharmaceuticals Inc | -0.007M |
| Solid Biosciences Inc | -38.49M |
| Dyne Therapeutics Inc | -179.84M |
| Sana Biotechnology Inc | -77.23M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -28.66M |
| Cash from Financing (Quarterly) | 46.77M |
| Free Cash Flow | -101.62M |
| Free Cash Flow Per Share (Quarterly) | -0.3609 |
| Free Cash Flow Yield | -28.81% |